Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC PBD-monoamide | 2093165-00-3 | 96.4% | 600.66 | C33H36N4O7 | 25 MG
SDP

Catalog No. 5000202490
Encompass_Preferred

PBD-monoamide is a modified pyrrolobenzodiazepine (PBD) dimer used as an antibody-drug conjugate (ADC) cytotoxin. It exhibits DNA-binding activity and reduces cell viability, and is commonly used as a payload intermediate in ADC synthesis and related biological studies.

  • Modified PBD dimer with DNA-binding activity
  • Used as an ADC payload intermediate in synthesis and research
  • Purity approximately 96.4%
  • Molecular weight 600.66 g/mol and formula C33H36N4O7
  • Store protected from light and under nitrogen at 4°C; in solvent store at -80°C for long-term

Catalog No. 50-002-02490 Supplier Medchemexpress LLC Supplier No. HY16125225MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

PBD-monoamide is a modified pyrrolobenzodiazepine (PBD) dimer used as an antibody-drug conjugate (ADC) cytotoxin. It exhibits DNA-binding activity and reduces cell viability, and is commonly used as a payload intermediate in ADC synthesis and related biological studies.

  • Modified PBD dimer with DNA-binding activity
  • Used as an ADC payload intermediate in synthesis and research
  • Purity approximately 96.4%
  • Molecular weight 600.66 g/mol and formula C33H36N4O7
  • Store protected from light and under nitrogen at 4°C; in solvent store at -80°C for long-term

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.